DOV vs SYRE · P/E 27, rev $4.24B vs $7.60B cap
Dover Corporation (DOV) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the DOV and SYRE stock pages for the full models.
Not investment advice.